C8H6N4O5
241.14 g/mol
APIDanger
1-[(E)-(5-nitrofuran-2-yl)methylideneamino]-(2,4,5-13C3)1,3-diazolidine-2,4-dione
CAS1217226-46-4
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
This compound is an isotope-labeled active pharmaceutical ingredient used in pharmaceutical manufacturing and research. Its structure incorporates carbon-13 labels and features an amide, an amine, and an aromatic heterocyclic ring system.
Raw material for pharmaceutical manufacturingResearch compound for isotope-labeled drug studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1217226-46-4
Related Compounds
ReferenceSame Category
Riboflavin-13C4,15N2
CAS1217461-14-7
pharmaceutical raw material
ReferenceSame Category
(3S,5E,7E)-(6,19,19-~2~H_3_)-9,10-Secoergosta-5,7,10,22-tetraene-3,25-diol
CAS1217467-39-4
pharmaceutical raw material
ReferenceSame Category
Alpelisib
CAS1217486-61-7
pharmaceutical raw material
ReferenceSame Category
N-[(2S)-2-{[(3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl}-3-(²H₅)phenylpropanoyl]glycine
CAS1217616-62-0
pharmaceutical raw material
Referencestereoisomer of
Nitrofurantoin monohydrate
CAS17140-81-7
pharmaceutical raw material
Referencestereoisomer of
1-[(5-nitro-2-furanyl)methylideneamino]imidazolidine-2,4-dione
CAS67-20-9
Antibacterial for lower urinary tract infections
Safety Reference
Danger
H302Harmful if swallowed
H317May cause an allergic skin reaction
H334May cause allergy or asthma symptoms or breathing difficulties if inhaled
Identifiers
IUPAC Name
1-[(E)-(5-nitrofuran-2-yl)methylideneamino]-(2,4,5-13C3)1,3-diazolidine-2,4-dione
InChIKey
NXFQHRVNIOXGAQ-PZGYLZBDSA-N
SMILES
[13CH2]1[13C](=O)N[13C](=O)N1/N=C/C2=CC=C(O2)[N+](=O)[O-]
Synonyms (10)
- 67-20-9 (Unlabeled)
- Nitrofurantoin 13C3